PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 76 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $23,000 | +15.0% | 54,200 | 0.0% | 0.00% | – |
Q2 2016 | $20,000 | -76.7% | 54,200 | -73.5% | 0.00% | – |
Q1 2016 | $86,000 | -42.3% | 204,314 | +60.5% | 0.00% | -100.0% |
Q4 2015 | $149,000 | +14.6% | 127,269 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $130,000 | -19.8% | 127,269 | +2.9% | 0.00% | 0.0% |
Q2 2015 | $162,000 | -10.0% | 123,687 | -7.2% | 0.00% | 0.0% |
Q1 2015 | $180,000 | -3.2% | 133,223 | -0.7% | 0.00% | 0.0% |
Q4 2014 | $186,000 | 0.0% | 134,134 | -1.7% | 0.00% | 0.0% |
Q3 2014 | $186,000 | -27.3% | 136,420 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $256,000 | +5.3% | 136,420 | +6.5% | 0.00% | 0.0% |
Q1 2014 | $243,000 | +42.1% | 128,125 | +4.2% | 0.00% | 0.0% |
Q4 2013 | $171,000 | +0.6% | 122,946 | +1.7% | 0.00% | 0.0% |
Q3 2013 | $170,000 | +198.2% | 120,900 | +175.1% | 0.00% | – |
Q2 2013 | $57,000 | – | 43,944 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |